In the BioHarmony Drug Report Database
Xifaxan (rifaximin) is a small molecule pharmaceutical. Rifaximin was first approved as Xifaxan on 2004-05-25. It is used to treat bacterial infections, diarrhea, and irritable bowel syndrome in the USA. Xifaxan’s patents are valid until 2029-10-02 (FDA).
Image (chem structure or protein)